Atom Mines

Atom Mines is a private Austin, Texas-based isotope production company focused on separated and tailored stable isotopes used in nuclear medicine and cancer therapy supply chains. The company appears to specialize in medical isotope separation, including ytterbium-176, a precursor used to produce lutetium-177 for targeted radiotherapies. Publicly available information suggests Atom Mines is positioned more as an enabling supply and technology platform than as a traditional drug developer with a broad in-house therapeutic pipeline. Its business is oriented toward supporting approved and emerging oncology radiopharmaceutical products by improving access to scarce precursor isotopes. Atom Mines has received grant and incubator backing and has been described by multiple business databases as an active private biotechnology company.